AQR Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Sell |
|
|||||
|
2025
Q1 | $250K | Sell |
|
|||||
|
2024
Q4 | $519K | Sell |
|
|||||
|
2024
Q3 | $776K | Buy |
|
|||||
|
2024
Q2 | $191K | Buy |
|
|||||
|
2024
Q1 | $93.6K | Sell |
|
|||||
|
2023
Q4 | $173K | Buy |
|
|||||
|
2023
Q3 | $110K | Buy |
|
|||||
|
2023
Q2 | $108K | Buy |
|
|||||
|
2023
Q1 | $107K | Sell |
|
|||||
|
2022
Q4 | $235K | Sell |
|
|||||
|
2022
Q3 | $266K | Buy |
|
|||||
|
2022
Q2 | $243K | Sell |
|
|||||
|
2022
Q1 | $350K | Sell |
|
|||||
|
2021
Q4 | $633K | Buy |
|
|||||
|
2021
Q3 | $550K | Buy |
|
|||||
|
2021
Q2 | $667K | Buy |
|
|||||
|
2021
Q1 | $425K | Sell |
|
|||||
|
2020
Q4 | $214K | Buy |
|
|||||
|
2020
Q3 | $173K | Buy |
|
|||||
|
2020
Q2 | $177K | Buy |
|
|||||
|
2020
Q1 | $65K | Buy |
|